Sept 29 (Reuters) – Metsera Inc: * METSERA REPORTS POSITIVE PHASE 2B RESULTS FOR FIRST- AND BEST-IN-CLASS ULTRA-LONG ACTING GLP-1 RA CANDIDATE MET-097I, ENABLING RAPID TRANSITION INTO PHASE 3 * METSERA INC – MET-097I SHOWS 14.1% WEIGHT LOSS AFTER 28 WEEKS * METSERA INC – MET-097I SHOWS CLASS-LEADING TOLERABILITY IN TRIALS * METSERA INC – DATA SUPPORTS PHASE 3 INITIATION IN LATE 2025 Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Venice [Italy], May 11: Young Indian art collector Abeer Vivek Abrol was among the notable…
Vadodara (Gujarat) [India], May 11: Ahead of Mother’s Day, Vasu Healthcare, a leading name in…
New Delhi [India], May 11: Dr.Harvansh Chawla, a distinguished legal expert and leader in international trade…
Sikkim [India], May 11: A new academic season is set to begin at MIT University Sikkim,…
Bengaluru (Karnataka) [India], May 11: Kennametal India Limited (KIL) reported revenues of ₹4031 million for…
Mumbai (Maharashtra) [India], May 8: The teaser of the much-awaited Hindi film Krishna Aur Chitthi…